Switching natalizumab to fingolimod - real life data from Austria

M Guger; C Enzinger; F Leutmezer; Jörg Kraus; S Kalcher; E Kvas; T Berger

Switching natalizumab to fingolimod - real life data from Austria

M Guger
, C Enzinger
, F Leutmezer
, Jörg Kraus
, S Kalcher
, E Kvas
, T Berger

Universitätsinstitut für Medizinisch-Chemische Labordiagnostik

Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung

Originalsprache	Englisch
Seiten (von - bis)	307-308
Fachzeitschrift	MULTIPLE SCLEROSIS
Jahrgang	25
Publikationsstatus	Veröffentlicht - 2019
Veranstaltung	35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS - Stockholm, SWEDEN Dauer: 11 Sept. 2019 → 13 Sept. 2019

Dieses zitieren

Guger, M., Enzinger, C., Leutmezer, F., Kraus, J., Kalcher, S., Kvas, E., & Berger, T. (2019). Switching natalizumab to fingolimod - real life data from Austria. MULTIPLE SCLEROSIS , 25, 307-308.

Guger, M ; Enzinger, C ; Leutmezer, F et al. / Switching natalizumab to fingolimod - real life data from Austria. in: MULTIPLE SCLEROSIS 2019 ; Jahrgang 25. S. 307-308.

@article{971082fb0c924c608eec1cdfe1cddf61,

title = "Switching natalizumab to fingolimod - real life data from Austria",

author = "M Guger and C Enzinger and F Leutmezer and J{\"o}rg Kraus and S Kalcher and E Kvas and T Berger",

year = "2019",

language = "English",

volume = "25",

pages = "307--308",

journal = "MULTIPLE SCLEROSIS ",

issn = "1352-4585",

publisher = "SAGE Publications",

note = "35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS ; Conference date: 11-09-2019 Through 13-09-2019",

}

Guger, M, Enzinger, C, Leutmezer, F, Kraus, J, Kalcher, S, Kvas, E & Berger, T 2019, 'Switching natalizumab to fingolimod - real life data from Austria', MULTIPLE SCLEROSIS , Jg. 25, S. 307-308.

Switching natalizumab to fingolimod - real life data from Austria. / Guger, M; Enzinger, C; Leutmezer, F et al.
in: MULTIPLE SCLEROSIS , Jahrgang 25, 2019, S. 307-308.

Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung

TY - JOUR

T1 - Switching natalizumab to fingolimod - real life data from Austria

AU - Guger, M

AU - Enzinger, C

AU - Leutmezer, F

AU - Kraus, Jörg

AU - Kalcher, S

AU - Kvas, E

AU - Berger, T

PY - 2019

Y1 - 2019

M3 - Abstract (Journal)

SN - 1352-4585

VL - 25

SP - 307

EP - 308

JO - MULTIPLE SCLEROSIS

JF - MULTIPLE SCLEROSIS

T2 - 35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS

Y2 - 11 September 2019 through 13 September 2019

ER -

Guger M, Enzinger C, Leutmezer F, Kraus J, Kalcher S, Kvas E et al. Switching natalizumab to fingolimod - real life data from Austria. MULTIPLE SCLEROSIS . 2019;25:307-308.